RAS-Targeted Strategies in Pancreatic Cancer Progress and Future Directions CME/CNE/CPE Marriott Marquis San Francisco Friday, January 9, 2026 | 6:30 PM - 8:00 PM PT

https://na.eventscloud.com/website/91375/ This January in San Francisco, join a panel of 3 leading experts for a 90-minute program on the evolving landscape of pancreatic adenocarcinoma (PDAC) treatment. This dynamic discussion will focus on the remarkable evolution of renin-angiotensin system (RAS) inhibitors in PDAC, tracing the journey from when RAS was considered undruggable to the latest data on novel mechanisms and therapies targeting RAS in its active state. Don't miss this opportunity to gain insights into the future of PDAC management and engage with the experts directly during a dedicated question-and-answer session. Not an official event of the 2026 ASCO® Gastrointestinal Cancers Symposium. Not sponsored, endorsed, or accredited by ASCO®, Association for Clinical Oncology, or Conquer Cancer®, the ASCO Foundation